Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1074

1.

Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy.

D'Amico AV, Renshaw AA, Sussman B, Chen MH.

JAMA. 2005 Jul 27;294(4):440-7.

PMID:
16046650
[PubMed - indexed for MEDLINE]
2.
3.

Prostate-specific antigen recurrence and mortality after conventional dose radiation therapy in select men with low-risk prostate cancer.

Petit JH, Chen MH, Loffredo M, Sussman B, Renshaw AA, D'Amico AV.

Cancer. 2006 Nov 1;107(9):2180-5.

PMID:
17009323
[PubMed - indexed for MEDLINE]
Free Article
4.

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.

Shipley WU, Thames HD, Sandler HM, Hanks GE, Zietman AL, Perez CA, Kuban DA, Hancock SL, Smith CD.

JAMA. 1999 May 5;281(17):1598-604.

PMID:
10235152
[PubMed - indexed for MEDLINE]
5.

Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors.

D'Amico AV, Chen MH, Catalona WJ, Sun L, Roehl KA, Moul JW.

Cancer. 2007 Jul 1;110(1):56-61.

PMID:
17530618
[PubMed - indexed for MEDLINE]
Free Article
6.

Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy.

Eggener SE, Roehl KA, Yossepowitch O, Catalona WJ.

J Urol. 2006 Oct;176(4 Pt 1):1399-403.

PMID:
16952643
[PubMed - indexed for MEDLINE]
7.

Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.

D'Amico AV, Hui-Chen M, Renshaw AA, Sussman B, Roehl KA, Catalona WJ.

J Urol. 2006 Dec;176(6 Pt 2):S11-5.

PMID:
17084157
[PubMed - indexed for MEDLINE]
8.

Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancer.

Krejcarek SC, Chen MH, Renshaw AA, Loffredo M, Sussman B, D'Amico AV.

Urology. 2007 Mar;69(3):515-9.

PMID:
17382156
[PubMed - indexed for MEDLINE]
9.

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A.

JAMA. 1998 Sep 16;280(11):969-74.

PMID:
9749478
[PubMed - indexed for MEDLINE]
10.

Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapy.

Nanda A, Chen MH, Moran BJ, Braccioforte MH, Dosoretz D, Salenius S, Katin M, Ross R, D'Amico AV.

Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):147-52. doi: 10.1016/j.ijrobp.2009.04.085. Epub 2009 Sep 8.

PMID:
19744800
[PubMed - indexed for MEDLINE]
11.

Pretreatment predictors of time to cancer specific death after prostate specific antigen failure.

D'Amico AV, Cote K, Loffredo M, Renshaw AA, Chen MH.

J Urol. 2003 Apr;169(4):1320-4.

PMID:
12629352
[PubMed - indexed for MEDLINE]
12.

Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.

Carter HB, Ferrucci L, Kettermann A, Landis P, Wright EJ, Epstein JI, Trock BJ, Metter EJ.

J Natl Cancer Inst. 2006 Nov 1;98(21):1521-7.

PMID:
17077354
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era.

D'Amico AV, Whittington R, Malkowicz SB, Cote K, Loffredo M, Schultz D, Chen MH, Tomaszewski JE, Renshaw AA, Wein A, Richie JP.

Cancer. 2002 Jul 15;95(2):281-6.

PMID:
12124827
[PubMed - indexed for MEDLINE]
Free Article
14.

Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence.

Wo JY, Chen MH, Nguyen PL, Renshaw AA, Loffredo MJ, Kantoff PW, D'Amico AV.

J Clin Oncol. 2009 Dec 10;27(35):6000-5. doi: 10.1200/JCO.2009.23.6067. Epub 2009 Oct 26.

PMID:
19858385
[PubMed - indexed for MEDLINE]
Free Article
15.

Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer.

D'Amico AV, Schultz D, Loffredo M, Dugal R, Hurwitz M, Kaplan I, Beard CJ, Renshaw AA, Kantoff PW.

JAMA. 2000 Sep 13;284(10):1280-3.

PMID:
10979115
[PubMed - indexed for MEDLINE]
16.

Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer.

Efstathiou JA, Chen MH, Renshaw AA, Loffredo MJ, D'Amico AV.

Cancer. 2007 Apr 15;109(8):1493-8.

PMID:
17340594
[PubMed - indexed for MEDLINE]
Free Article
17.

Predictors of mortality after androgen-deprivation therapy in patients with rapidly rising prostate-specific antigen levels after local therapy for prostate cancer.

Rodrigues NA, Chen MH, Catalona WJ, Roehl KA, Richie JP, D'Amico AV.

Cancer. 2006 Aug 1;107(3):514-20.

PMID:
16795068
[PubMed - indexed for MEDLINE]
Free Article
18.

Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.

Kupelian P, Kuban D, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A.

Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):415-9.

PMID:
15667961
[PubMed - indexed for MEDLINE]
19.

Prostate-specific antigen velocity and the detection of gleason score 7 to 10 prostate cancer.

Punglia RS, Cullen J, McLeod DG, Chen Y, D'Amico AV.

Cancer. 2007 Nov 1;110(9):1973-8.

PMID:
17886252
[PubMed - indexed for MEDLINE]
Free Article
20.

Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals.

Scholz M, Lam R, Strum S, Jennrich R, Johnson H, Trilling T.

Urology. 2007 Sep;70(3):506-10.

PMID:
17905106
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk